Doctor Zhehao Dai

Doctor Zhehao Dai

The University of Tokyo, Tokyo (Japan)

Member of:

Dr. Zhehao Dai is a young cardiologist at The University of Tokyo Hospital, Tokyo, Japan. He has great interest in chronic and acute heart failure, acute and intensive cardiac care, cardiovascular imaging, and pulmonary circulation. He has been dedicated in clinical research projects regarding the above-mentioned fields in the past decade in multiple institutes.

Presentations

Myocardial DNA damage is responsible for the relationship between genotype and treatment response in patients with dilated cardiomyopathy

Event: ESC Congress 2024

Topic: Dilated Cardiomyopathy

Session: Deeper insights into cardiomyocyte dysfunction

Access

Myocardial DNA damage combined with genotype predicts heart failure outcome in various underlying diseases

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: New pathophysiological insights of heart failure

Access

Percutaneous transluminal septal myocardial ablation markedly reduces energy loss in hypertrophic obstructive cardiomyopathy: a four-dimensional flow magnetic resonance imaging study

Event: ESC Congress 2020

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial Disease ePosters

Access

An exploratory analysis for the optimal monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Biomarkers in heart failure

Access

Early initiation of oral beta-blocker improves long-term survival in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention.

Event: ESC Congress 2017

Topic: Adjunctive medical therapy

Session: Acute coronary syndromes

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Zhehao Dai

Biography

Contributor content

Myocardial DNA damage is responsible for the relationship between genotype and treatment response in patients with dilated cardiomyopathy

Myocardial DNA damage combined with genotype predicts heart failure outcome in various underlying diseases

Percutaneous transluminal septal myocardial ablation markedly reduces energy loss in hypertrophic obstructive cardiomyopathy: a four-dimensional flow magnetic resonance imaging study

An exploratory analysis for the optimal monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure

Early initiation of oral beta-blocker improves long-term survival in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention.

ESC 365 is supported by

Doctor Zhehao Dai Follow

Biography

Contributor content

Myocardial DNA damage is responsible for the relationship between genotype and treatment response in patients with dilated cardiomyopathy

Myocardial DNA damage combined with genotype predicts heart failure outcome in various underlying diseases

Percutaneous transluminal septal myocardial ablation markedly reduces energy loss in hypertrophic obstructive cardiomyopathy: a four-dimensional flow magnetic resonance imaging study

An exploratory analysis for the optimal monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure

Early initiation of oral beta-blocker improves long-term survival in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention.

ESC 365 is supported by

Doctor Zhehao Dai